Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients

被引：2
作者：
Wang, Ji-Gan [1 ]
Chen, Rui [1 ]
Wang, Li-Chuan [1 ]
机构：
[1] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Nanning, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 09期
关键词：
HEPATOCELLULAR-CARCINOMA; VIRAL LOAD; MORTALITY; RISK; HBV;
D O I：
10.1111/apt.16323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1048 / 1049
页数：2
相关论文
共 10 条
[1]   Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study [J].
Chen, Gang ;
Lin, Wenyao ;
Shen, Fumin ;
Iloeje, Uchenna H. ;
London, W. Thomas ;
Evans, Alison A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (08) :1797-1803
[2]   Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection: A Systematic Review and Meta-analysis [J].
Choi, Won-Mook ;
Choi, Jonggi ;
Lim, Young-Suk .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (02) :246-+
[3]   Comparison of 48-week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta-analysis [J].
Con, Danny ;
Goodwin, Thomas ;
Majeed, Ammar ;
Roberts, Stuart ;
Kemp, William .
JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) :40-50
[4]   Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection [J].
Hung, Ivan F. N. ;
Poon, Ronnie T. P. ;
Lai, Ching-Lung ;
Fung, James ;
Fan, Sheung-Tat ;
Yuen, Man-Fung .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (07) :1663-1673
[5]   Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686
[6]   Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance [J].
Kuang, X. -J. ;
Jia, R. -R. ;
Huo, R. -R. ;
Yu, J. -J. ;
Wang, J. -J. ;
Xiang, B. -D. ;
Li, L. -Q. ;
Peng, Z. ;
Zhong, J. -H. .
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (09) :1026-1037
[7]   Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort [J].
Pol, Stanislas .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (05) :616-629
[8]   Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis [J].
Teng, Yu-Xian ;
Li, Min-Jun ;
Xiang, Bang-De ;
Zhong, Jian-Hong .
GUT, 2020, 69 (10) :1900-1901
[9]   Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance [J].
Yip, Terry Cheuk-Fung ;
Chan, Henry Lik-Yuen ;
Wong, Vincent Wai-Sun ;
Tse, Yee-Kit ;
Lam, Kelvin Long-Yan ;
Wong, Grace Lai-Hung .
JOURNAL OF HEPATOLOGY, 2017, 67 (05) :902-908
[10]   A Meta-Analysis Comparing the Efficacy of Entecavir and Tenofovir for the Treatment of Chronic Hepatitis B Infection [J].
Zuo, Shan-Ru ;
Zuo, Xiao-Cong ;
Wang, Chun-Jiang ;
Ma, Yu-Tao ;
Zhang, Hao-Ye ;
Li, Zuo-Jun ;
Song, Li-Ying ;
Deng, Zhen-Zhen ;
Liu, Shi-Kun .
JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (03) :288-297
1